Cáncer de mama triple negativo: otra enfermedad y nuevo reto / Triple negative breast cancer: another disease and a new challenge
Contreras Castillo, Ana Cecilia.
Rev. venez. oncol
; 33(1): 46-59, mar. 2021. tab
Article
in Spanish
| LIVECS, LILACS | ID: biblio-1147479
The Triple Negative breast cancer is a molecular subtype characterized by no expression of the estrogen, the progesterone and the HER2 protein receptors. They represents 10 % to 15 % of all the breast cancer subtypes with an impact on the prognosis and in the treatment lines; is negative for the hormone receptors and for the HER2, hormonal and the anti-HER2 therapeutics do not count for the management of them. The products targeting specific to this category are not yet available(AU)
Responsible library:
VE1.1
Fulltext